Target intelligence / Profile preview

Infarcted and peri-infarct myocardium

Molecular classification
Other
01

Overview

Infarcted and peri-infarct myocardium refers to the anatomical regions of the heart muscle affected by a myocardial infarction (MI). The infarcted zone consists of necrotic tissue where cardiomyocytes have died due to prolonged ischemia, eventually being replaced by a non-contractile collagen scar [1]. The peri-infarct myocardium, or border zone, is the surrounding area of viable but stressed tissue that undergoes significant pathological changes, including inflammation, oxidative stress, and structural remodeling [2]. This region is a critical focus for therapeutic intervention, as salvageable myocytes in the peri-infarct zone can be protected to limit total infarct size and prevent the progression to chronic heart failure [3]. While not a single molecular target, this tissue environment is the site of action for various pharmacological agents, such as ACE inhibitors and beta-blockers, as well as emerging regenerative therapies like stem cell transplantation and gene therapy [4]. Understanding the molecular landscape of these zones is essential for developing precision medicines that target specific pathways like fibrosis or angiogenesis within the damaged heart [5].

Other names
Myocardial infarct border zonePeri-infarct zoneIschemic myocardiumNecrotic myocardiumInfarct zone
02

Mechanism of action

Drugs targeting this region typically aim to reduce myocardial oxygen demand, inhibit adverse ventricular remodeling, suppress inflammatory cascades, or promote angiogenesis and cellular repair within the salvageable border zone.

03

Biological functions

Tissue remodelingInflammationApoptosisFibrosisAngiogenesisWound healing
04

Disease associations

Cardiovascular diseaseInflammation
05

Safety considerations

Risk of ventricular arrhythmiasMyocardial ruptureHypotensionElectrolyte imbalances during remodeling
06

Interacting drugs

Lisinopril

5 more in the full profile.

07

Biomarkers

Cardiac troponin ICardiac troponin TCreatine kinase-MB (CK-MB)B-type natriuretic peptide (BNP)Late gadolinium enhancement (LGE) on MRI

Beyond the preview

Go deeper on Infarcted and peri-infarct myocardium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infarcted and peri-infarct myocardium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call